Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.
Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.
- 1:30 p.m. Anika Therapeutics completed enrollment of 242 subjects in a follow-on study to evaluate the safety of injectable Cingal® to treat knee osteoarthritis. (Source: Anika Therapeutics, Inc.)
- Cartiva raised US $6MM of a potential $8.5MM offering. Products developed by Cartiva include a synthetic cartilage implant to treat great toe osteoarthritis and the ProxiFuse™ Hammertoe Correction system. (Source: Form D, SEC.gov; www.cartiva.net)
- 8:00 a.m. One-year results from a pilot feasibility study comparing Vexim's SpineJack® to Medtronic's balloon in the treatment of vertebral compression fractures in osteoporosis patients demonstrated SpineJack to be highly effective, resulting in greater/sustainable restoration of vertebral height, faster pain relief and shorter OR time. (Source: Vexim)